For Investors

Press Releases

Lifeward Successfully Closes on Strategic Partnership with Oramed

03/25/26

HUDSON, Mass. and YOKNEAM ILLIT, Israel, March 25, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced that it has closed on

Read More
Read More

Lifeward Reports Fourth Quarter and Full Year 2025 Financial Results

03/18/26

Advancing t ransformation into a d iversified b iomedical i nnovation c ompany with a c lear p ath to c ash f low p ositiv e Oramed s trategic t ransaction r eceives   s hareholder a pproval;   Lifeward g ain s   n ew o ral p rotein d elivery t echnology p latform Lifeward a lready e xecuting n ew

Read More
Read More

Lifeward Receives Shareholder Approval to Close on Strategic Partnership with Oramed—Creating Diversified Biomedical Company

03/13/26

Position s Lifeward as a diversified biomedical innovation company with clear path to profitability Integration of Oramed’s POD™ oral delivery technology expands Lifeward into biotech markets while Oramed funds the platform’s clinical development Provides Lifeward access to up to $47 million of

Read More
Read More

Lifeward Regains Compliance with Nasdaq Minimum Bid Price Requirement

03/11/26

HUDSON, Mass. and YOKNEAM ILLIT, Israel, March 11, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced it has received a

Read More
Read More

Lifeward to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026

03/10/26

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, March 10, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced that the Company

Read More
Read More

Lifeward Announces Collaboration With Shirley Ryan AbilityLab to Expand Access for the ReWalk Personal Exoskeleton

03/02/26

Clinic  d ays offered   at Shirley Ryan   AbilityLab, the #1 ranked rehabilitation hospital   for 35 consecutive years,   with the goal of   a ccelerat ing   p ersonal e xoskeleton a doption S treamlined pathway from evaluation to real-world use of ReWalk for people living with spinal cord injury

Read More
Read More

Lifeward to Acquire Powered Upper Body Exoskeleton with AI Capabilities Designed to Restore Function to Stroke Survivors

02/25/26

IP and technology acquisition is expected to be highly accretive and to advance Lifeward’s position as a diversified biomedical innovation company Will Expand Lifeward’s portfolio beyond lower-limb solutions, creating a differentiated, whole-body neuro-rehabilitation portfoli o Will Strengthen

Read More
Read More

Lifeward Announces Reverse Share Split

02/20/26

Reverse split initiated as Lifeward enters strategic partnership agreement and repositions as MedTech innovation company HUDSON, Mass. and YOKNEAM ILLIT, Israel, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical

Read More
Read More

Lifeward’s ReWalk™ Personal Exoskeleton Now Covered by Aetna, Coverage Expands to Include Three of the Largest Medicare Advantage Insurers

02/17/26

Aetna joins Humana and United Healthcare in providing Medicare Advantage coverage for beneficiaries who meet medical necessity criteria for the ReWalk Personal Exoskeleton Together, these three national Medicare Advantage insurers represent approximately 16 million beneficiaries across the United

Read More
Read More

Lifeward Enters Transformative Strategic Investment and Partnership Agreement with Oramed to Create a Diversified Biomedical Innovation Company

01/13/26

Positions Lifeward as a MedTech platform with a clear path to cashflow positive and long-term Biotech upside potential Up to $47 million strategic investment from Oramed and another investor is intended to provide Lifeward cash runway to profitability and diversify its portfolio across MedTech and

Read More
Read More

Lifeward Appoints Bob Marshall as Chairman of the Board

12/19/25

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel , Dec. 19, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd ., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology designed to transform the lives of people with physical limitations or disabilities, announced today that

Read More
Read More

Lifeward Expands International Distribution of its ReWalk® Personal Robotic Exoskeleton into Mexico, Thailand, and the United Arab Emirates

12/17/25

Distribution agreement with Singapore -based Verita Neuro will provide patients the ReWalk Personal Exoskeleton as part of its multi-layered treatment modalities New delivery model for ReWalk will   integrate in-patient training and rehabilitation   to support clinical adoption in physical

Read More
Read More
Displaying 1 - 12 of 345